Inhibikase Therapeutics, Inc. IKT
2.06
(0.04)
(1.90%)
as of 25 Sep
- Market cap
- $293.0M
- P/E
- 0.0×
Follow IKT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
15.50 | 29.83 | 21.54 | 11.55 | |
Current Ratio |
15.82 | 30.14 | 21.70 | 11.73 | |
Net Debt/EBITDA |
7.55 | 9.55 | 12.98 | 6.07 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.74 | 0.59 | 0.89 | |
Capex/Depreciation |
— | — | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.07) | (0.07) | (0.08) | (0.12) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.07) | (0.07) | (0.08) | (0.12) | |
Cash per Share |
0.91 | 0.99 | 1.82 | 0.86 | |
Shareholders Equity per Share |
0.88 | 0.97 | 1.76 | 0.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.88 | 0.97 | 1.76 | 0.81 | |
Free Cash Flow |
(12.44) | (12.06) | (7.52) | (10.59) | |
Working Capital |
152.08 | 166.46 | 171.81 | 71.84 | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
Net Current Asset Value |
152.08 | 166.46 | 171.81 | 71.84 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.85 | 1.64 | 1.05 | 1.57 | |
Average Assets |
126.22 | 133.81 | 139.90 | 41.99 | |
Average Common Equity |
116.69 | 126.68 | 133.89 | 36.18 |
Columns are period end dates